These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17713021)

  • 1. Interleukin-7 immunotherapy.
    Sportès C; Gress RE
    Adv Exp Med Biol; 2007; 601():321-33. PubMed ID: 17713021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 in allogeneic transplant: clinical promise and potential pitfalls.
    Snyder KM; Mackall CL; Fry TJ
    Leuk Lymphoma; 2006 Jul; 47(7):1222-8. PubMed ID: 16923550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy.
    Gao J; Zhao L; Wan YY; Zhu B
    Int J Mol Sci; 2015 May; 16(5):10267-80. PubMed ID: 25955647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-2 cytokine family in cancer immunotherapy.
    Sim GC; Radvanyi L
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospect of IL-2, IL-7, IL-15 and IL-21 for HIV immune-based therapy.
    Diallo M; Zheng Y; Chen X; He Y; Zhou H; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1037-45. PubMed ID: 22169717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
    Rosenthal R; Groeper C; Bracci L; Adamina M; Feder-Mengus C; Zajac P; Iezzi G; Bolli M; Weber WP; Frey DM; von Holzen U; Oertli D; Heberer M; Spagnoli GC
    J Immunother; 2009 Apr; 32(3):252-61. PubMed ID: 19242375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
    Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
    Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common gamma chain cytokines in combinatorial immune strategies against cancer.
    Pulliam SR; Uzhachenko RV; Adunyah SE; Shanker A
    Immunol Lett; 2016 Jan; 169():61-72. PubMed ID: 26597610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytokines in T-cell memory in health and disease.
    Raeber ME; Zurbuchen Y; Impellizzieri D; Boyman O
    Immunol Rev; 2018 May; 283(1):176-193. PubMed ID: 29664568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7: maintaining T-cell memory and achieving homeostasis.
    Bradley LM; Haynes L; Swain SL
    Trends Immunol; 2005 Mar; 26(3):172-6. PubMed ID: 15745860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.
    Wang C; Kong L; Kim S; Lee S; Oh S; Jo S; Jang I; Kim TD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
    von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
    Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7: biology and potential clinical applications.
    Appasamy PM
    Cancer Invest; 1993; 11(4):487-99. PubMed ID: 8324652
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer.
    Fewkes NM; Mackall CL
    Cancer J; 2010; 16(4):392-8. PubMed ID: 20693852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic applications of IL-15.
    Croce M; Orengo AM; Azzarone B; Ferrini S
    Immunotherapy; 2012 Sep; 4(9):957-69. PubMed ID: 23046239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer.
    Ramesh R; Ioannides CG; Roth JA; Chada S
    Methods Mol Biol; 2010; 651():241-70. PubMed ID: 20686970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
    Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
    Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.